Clinical Trials Browser

Phase 2 × Lymphoma × tafasitamab × Clear all

NCT07030699 2026-04-07

ECLAT

Phase 2 Withdrawn

Lymphoma

NCT07502872 2026-03-31

TPG

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07126236 2025-08-17

REPIFIR

Phase 2 Recruiting

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse